Zdrowie i gospodarka · 03/07/1995
FDA Introduces Changes to Refusal to File Review Committee Process
The FDA is implementing a new procedure allowing applicants to attend the meeting where the Refusal to File review committee evaluates their application, in an effort to enhance understanding and participation in the process.
Source: Federal Register — Food and Drug AdministrationOpen original release →